What have snakes taught us about integrins?

Cellular and Molecular Life Sciences

Volumn 54, Issue 6, 1998, Pages 527-540

  Huang, T F ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

ADAMs; Cell fusion; Cell matrix interaction; Haemorrhage; Integrin (IIb) 3, 2 1, (V) 3; Metalloprotease; Platelet aggregation; Snake venom disintegrin

Indexed keywords

DISINTEGRIN; INTEGRIN; METALLOPROTEINASE; SNAKE VENOM; VIPER VENOM;

ARTICLE; CELL FUSION; CELL INTERACTION; EXTRACELLULAR MATRIX;

AMINO ACID SEQUENCE; BLOOD PLATELETS; DISINTEGRINS; INTEGRINS; METALLOPROTEINS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SNAKE VENOMS; THROMBOSIS;

EID: 0031814234     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050181     Document Type: Article

References (154)

1. Ouyang C. (1957) The effects of Formosan snake venoms on blood coagulation in vitro. J. Formosan Med. Assoc. 56: 435-448
2. Jimenez-Porras J. M. (1968) Pharmacology of peptides and proteins in snake venoms. Ann. Rev. Pharmacol. 8: 299-318
3. Ouyang C., Teng C. M. and Huang T. F. (1987) Characterization of snake venom principles affecting blood coagulation and platelet aggregation. Asia Pacific J. Pharmacol. 2: 169-176
4. Ouyang C., Teng C. M. and Huang T. F. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30: 945-966
5. Lee C. Y. (1972) Chemistry and pharmacology of polypeptide toxins in snake venoms. Ann. Rev. Pharmacol. 12: 265-286
6. Seegers W. H. and Ouyang C. (1979) Snake venom and blood coagulation. In: Snake Venoms, Handbook of Experimental Pharmacology, vol. 52, pp. 684-750. Lee C. Y. (ed.), Springer-Verlag, Berlin
7. Iwanaga S. and Suzuki T. (1979) Enzymes in snake venom: In: Snake Venoms, Handbook of Experimental Pharmacology, vol. 52. pp. 61-158, Lee C. Y. (ed.), Springer-Verlag, Berlin
8. Bell Jr. W. R. (1985) Clinical trials with ancrod. In: Hemostasis and Animal Venoms. pp. 541-551, Markland F. S. (ed.), Marcel Dekker, New York
9. Coller B. S., Anderson K. and Weisman H. F. (1995) New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb. Haemost. 74: 302-308
10. The EPIC investigators. (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330: 956-961
11. Topol E. J., Califf R. M., Weisman H. F., Ellis S. G., Tcheng J. E., Worley S. et al. (1994) Randomised trial of coronary intervetion with antibody against platelet GPIIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 343: 881-886
12. Teng C. M. and Huang T. F. (1991) Snake venom consituents that affect platelet function. Platelets 2: 77-87
13. Teng C. M. and Huang T. F. (1991) Inventory of exogenous inhibitors of platelet aggregation. Thromb. Haemostas. 65: 624-626
14. Gould R. J., Polokoff M. A., Friedman P. A., Huang T. F., Holt J. C., Cook J. C. et al. (1990) Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195: 168-131
15. Huang T. F. and Niewiarowski S. (1994) The naturally-occurring antagonists of platelet fibrinogen receptor. J. Toxicol. Toxin Rev. 13: 253-273
16. Niewiarowski S., McLane M. A., Kloczewiak M. and Stewart G. J. (1994) Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol. 31: 289-300
17. Hynes R. O. (1987) Integrins: a family of cell surface receptors. Cell 48: 549-554
18. Hynes R. O. (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69: 11-25
19. Takeya H., Nishida S., Nishino N., Makinose Y., Omori-Satoh T., Nikai T. et al. (1993) Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. J. Biochem. 113: 473-483
20. Hite L. A., Shannon J. D., Bjarnason J. B. and Fox J. W. (1992) Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalaus atrox. Evidence for signal, zymogen and disintegrin-like structure. Biochemistry 31: 6203-6211
21. Paine M. J., Desmond H. P., Theakston R. O. G. and Crampton J. M. (1992) Purification, cloning and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. J. Biol. Chem. 267: 22869-22876
22. Wolfsberg T. G., Bazan J. F., Blobel C. P., Myles D. G., Primakoff P. and White J. M. (1993) The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: structural, functional and evolutionary implications. Proc. Natl. Acad. Sci. USA 90: 10783-10787
23. Huovila A.-P. J., Almeida E. A. C. and White J. M. (1996) ADAMs and cell fusion Curr. Opion. Cell Biol. 8: 692-699
24. Wolfsberg T. G., Primakoff P., Myles D. G. and White J. M. (1995) ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131: 275-278
25. Wolfsberg T. G. and White J. M. (1996) ADAMs in fertilization and development. Dev. Biol. 180: 389-401
26. Ginsberg M. H., Loftus J. C. and Plow E. F. (1988) Cytoadhesion, integrins and platelet adhesion. Thromb. Haemost. 59: 1-6
27. 2+-dependent adhesion of platelets to collagen. J. Cell Biol. 108: 1917-1924
28. Stein B., Fuster V., Halperin J. L. and Chesebro J. H. (1989) Antithrombotic therapy in cardiac disease: an emerging approach based on pathogenesis and risk. Circulation 80: 1501-1513
29. Coller B. S. (1990) Platelets and thrombolytic therapy. N. Engl. J. Med. 322: 33-42
30. George J. N., Caen J. P. and Nurden A. T. (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 75: 1383-1395
31. Nieuwenhuis H. K., Akkerman J. W. N., Houdijk W. P. M. and Sixma J. J. (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein la. Nature 318: 470-472
32. Nieuwenhuis H. K., Sakariassen K. S., Houdijk W. P. M., Nievelstein P. F. E. M. and Sixma J. J. (1986) Deficiency of platelet membrane glycoprotein la associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 68: 692-695
33. Ouyang C. and Huang T. F. (1983) Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim Biophys Acta 757: 332-341
34. Huang T. F. and Ouyang C. (1984) Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb. Res. 33: 125-138
35. Teng C. M., Ma Y. H. and Ouyang C. (1985) Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim. Biophys. Acta 841: 8-14
36. Ouyang C. H., Ma Y. H., Jih H. C. and Teng C. M. (1985) Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim. Biophys. Acta 841: 1-7
37. Huang T. F., Wu Y. J. and Ouyang C. (1987) Action mechanism of the platelet aggregation inhibitor from Calloselasma rhodostoma venom. Biochim. Biophys. Acta 925: 248-257
38. Ouyang C., Yeh H. I. and Huang T. F. (1983) A potent platelet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 21: 797-804
39. Huang T. F., Yeh H. I. and Ouyang C. (1984) Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (Mamushi) snake venom. Toxicon 22: 243-251
40. Huang T. F., Holt C. J., Lukasiewicz H. and Niewiarowski S. (1987) Trigramin: a low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem. 262: 16157-16163
41. Huang T. F., Holt J. C., Kirby E. P. and Niewiarowski S. (1989) Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 28: 661-666
42. Gartner T. K. and Bennett J. S. (1985) The tetrapeptide analogue of cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem. 260: 11891-11894
43. Scarborough R. M., Rose J. W., Hsu M. A., Phillips D. R., Fried V. A., Campbell A. M. et al. (1991) Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266: 9359-9362
44. McDowell R. S., Dennis M. S., Louie A., Schuster M., Mulkerrin M. G. and Lazarus R. A. (1992) Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry 31: 4766-4772
45. Mazur P., Henzel W. J., Seymour J. L. and Lazarus R. A. (1991) Potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata. Eur. J. Biochem. 202: 1073-1082
46. Seymour J. L., Henzel W. J., Nevins B., Stults J. T. and Lazarus R. A. (1990) Decorsin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J. Biol. Chem. 265: 10143-10147
47. Huang T. F., Liu C. Z., Ouyang C. and Teng C. M. (1991) Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide. as fibrinogen receptor antagonist. Biochem. Pharmacol. 42: 1209-1219
48. Huang T. F., Sheu J. R., Teng C. M., Chen S. W. and Liu C. S. (1991) Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide. is a specific antagonist of platelet membrane glycoprotein IIb/IIIa complex. J. Biochem. 109: 328-334
49. Gan Z. R., Gould R. J., Jacobs J. W., Friedman P. A. and Polokoff M. A. (1988) Echistatin: a potent platelet aggregation inhibitor from the venom of the viper Echis carinatus. J. Biol. Chem. 263: 19827-19832
50. Dennis M. S., Henzel W. J., Pitti R. M., Lipari M. T., Napier M. A., Deisher T. A. et al. (1990) Platelet glycoprotein IIb/IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. USA 87: 2471-2475
51. Cook J. J., Huang T. F., Rucinski B., Stezyzewski M., Tuma R. F., Williams J. A. et al. (1989) Inhibition of platelet haemostatic plug formation by trigramin, a novel RGD-peptide. Am. J. Physiol. 256: H1038-1043
52. Shebuski R. J., Ramjit D. R., Sitko G. R., Lumma P. K. and Garsky U. M. (1990) Prevention of canine coronary artery thrombosis with echistatin, a potent inhibitor of platelet aggregation from the venom of viper, Echis carinatus. Thromb. Haemost. 64: 576-581
53. Yasuda T., Gold H. K., Leinbach R. G., Yaoita H., Fallon J. T., Guerrero L. et al. (1991) Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation 83: 1038-1047
54. Rote W. E., Mu D. X., Roncinski E. A., Frelinger III A. L. and Lucchesi B. R. (1993) Prevention of experimental carotid artery thrombosis by applaggin. J. Pharmacol. Exp. Ther. 267: 809-814
55. Sheu J. R. and Huang T. F. (1994) Ex vivo and in vivo antithrombotic effect of triflavin, an RGD-containing peptide. J. Pharm. Pharmacol. 46: 58-62
56. Shigeta O., Gluszko P., Downing S. W., Lu W., Niewiarowski S. and Edmund W. H. (1992) Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin. Circulation 86: (Suppl. II): 398-404
57. Beviglia L., Poggi A., Rossi C., McLane M. A., Cala Brese R., Scanziani R. et al. (1993) Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins. Thromb. Res. 71: 301-315
58. Frank J. D., Gould R. J., Schaffer L. W., Davidson J. T., Gibson R. E., Patrick D. H. et al. (1992) Immunocytochemical localization of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following induction of thrombocytopenia. Histochemistry 97: 355-360
59. Schrör K. (1995) Antiplatelet drug: a comparative review. Drugs 50: 7-28
60. Pierschbacher M. D. and Ruoslahti E. (1984) Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30
61. Weller T., Alig L., Muller M. H., Kouns W. C. and Steiner B. (1994) Fibrinogen receptor antagonists a novel class of promising antithrombotics. Drugs Future 19: 461-476
62. Adler M., Lazarus R. A., Dennis M. S. and Wagner G. (1991) Solution structure of kistrin, a potent platelet aggregation inhibitor of GPIIb/IIIa antagonist. Science 253: 445-448
63. Saudek V., Atkinson R. A. and Pelton J. T. (1991) Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30: 7369-7372
64. Cheng H. Y., Davis L. L. and Holl W. W. (1993) Preparation and properties of a fibrinogen receptor antagonist containing the Arg-Gly-Asp sequence and nitroxide radicals. Bioorg. Med. Chem. Lett. 3: 1179-1184
65. Kopple K. D., Baures P. W., Bean J. W., D'Ambrosio C. A., Hughes J. L., Peishoff C. E. et al. (1992) Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: solution and crystal studies. J. Am. Chem. Soc. 114: 9615-9623
66. Barker P. L., Bullens S., Bunting S., Burdick D. J., Chang K. S., Deisher T. et al. (1992) Cyclic RGD peptide analogues as antiplatelet antithrombotics. J. Med. Chem. 35: 2040-2048
67. Berthel S. J. and Olson G. L. (1993) Cyclic RGD peptide analogues as antiplatelet antithrombotics. Chemtracts 6: 42-47
68. Lefkovits J., Plow E. F. and Topol E. J. (1995) Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med. 332: 1553-1559
69. Lefkovits J. and Topol E. J. (1996) Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease. Eur. Heart. J. 17: 9-18
70. Coller B. S. (1992) Antiplatelet agents in the prevention and therapy of thrombosis. Ann. Rev. Med. 43: 171-180
71. Coller B. S. (1985) A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb-IIIa complex. J. Clin. Invest. 76: 101-108
72. Liu C. Z., Wang Y. W., Shen M. C. and Huang T. F. (1994) Analysis of human platelet glycoprotein IIb/IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb. Haemost. 72: 919-925
73. Ault K. A. and Mitchell J. (1994) Analysis of platelets by flow cytometry. In: Methods in Cell biology: Flow cytometry. vol. 42, pp. 275-294, Darzynkiewicz Z., Robinson, J. P., Crissman H. A. (eds.), Academic Press, San Diego
74. Ginsberg M. H., Frelinger A. L., Lam S. C., Forsyth J., McMillan R., Plow E. F. et al. (1990) Analysis of platelet aggregation disorders based on flow cytometric analysis of mestrane glycoprotein Ib-IIIa with conformation-specific monoclonal antibodies. Blood 76: 2017-2023
75. Shattil S. J., Cunningham M. and Hoxie J. A. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70: 307-315
76. Johnston G. I., Heptinstall S., Robins R. A. and Price M. R. (1984) The expression of glycoproteins on single blood platelets from healthy individuals and from patients with congenital bleeding disorders. Biochem. Biophys. Res. Commun. 123: 1091-1098
77. Tschoepe D., Spangenberg P., Esser J., Schwippert B., Kehrel B., Boesen P. et al. (1990) Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 11: 652-656
78. Jennings L. K., Ashman R. A., Wang W. C. and Dockter M. E. (1986) Analysis of human platelet glycoprotein IIb/IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood 68: 173-179
79. Yasuda T., Gold H. K., Fallon J. T., Leinbach R. C., Guerrero J. L., Scudder L. E. et al. (1988) Monoclonal antibody against the platelet glycoprotein (GP IIb/IIIa) receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J. Clin. Invest. 81: 1284-1291
80. Gold H. K., Coller B. S., Yasuda T., Saito T., Fallon J. T., Guerrero J. L. et al. (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in canine preparation. Circulation 77: 670-677
81. 2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. J. Clin. Invest. 86: 651-659
82. Kohmura C., Gold H. K., Yasuda T., Holt R., Nedelman M. A., Guerrero J. L. et al. (1993) A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons. Arterioscler. Thromb. 13: 1837-1842
83. Kleiman N. S., Ohman E. M., Califf R. M., Geoge B. S., Kereiakes D., Aguirre F. V. et al. (1993) Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 pilot study. J. Am. Coll. Cardiol. 22: 381-389
84. Tcheng J. E., Ellis S. G., George B. S., Kereiakes D. J., Kleiman N. S., Talley J. D. et al. (1994) Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 90: 1757-1764
85. Coller B. S., Lang D. A. and Scudder L. E. (1997) Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 95: 860-867
86. Liu C. Z., Peng H. C. and Huang T. F. (1995) Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis. Toxicon 33: 1289-1298
87. Liu C. Z., Hur B. T. and Huang T. F. (1996) Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins. Thromb. Haemostas. 76: 585-591
88. Knudsen K. A., Tuszynski G. P., Huang T. F. and Niewiarowski S. (1988) Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp. Cell. Res. 179: 42-49
89. Savage B., Marzec U. M., Chao B. H., Harker L. A., Maraganone J. M. and Ruggeri Z. M. (1990) Binding of the snake venom-derived proteins applagin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb IIIa complex inhibits receptor function. J. Biol. Chem. 265: 11766-11772
90. Rucinski B., Niewiarowski S., Holt J. C., Soszka T. and Knudsen K. A. (1990) Batroxostatin, an Arg-Gly-Asp containing peptide from Bothrops atrox, a potent inhibitor of platelet aggregation and cell interaction with libronectin. Biochim. Biophys. Acta 1054: 257-262
91. Soszka T., Kriudsen K. A., Beviglia L., Cosmo R., Poggi A. and Niewiarowski S. (1991) Inhibition of murine melanoma cell matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell. Res. 196: 6-12
92. Sheu J. R., Lin C. H., Chung J. L., Teng C. M. and Huang T. F. (1992) Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn. J. Cancer. Res. 83: 885-893
93. Sheu J. R., Lin C. H. and Huang T. F. (1994) Triflavin, an antiplatelet peptide inhibits tumor cell-extracellular matrix adhesion via an RGD-dependent mechanism. J. Lab. Clin. Med. 123: 256-263
94. Sheu J. R., Lin C. H., Peng H. C., Teng C. M. and Huang T. F. (1993) Triflavin, an RGD-containing antiplatelet peptide, inhibits tumor cell-induced platelet aggregation. Jpn. J. Cancer Res. 84: 1062-1071
95. Sheu R. S. and Huang T. F. (1996) Triflavin. an Arg-Gly-Asp-containing peptide, inhibits B16F10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells. J. Biomed. Sci. 3: 359-364
96. Scarborough R. M., Rose J. W., Naughton M A., Phillips D. R., Nannizzi L., Arfsten A. et al. (1993) Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J. Biol. Chem. 268: 1058-1065
97. Sheu J. R., Lin C. H., Chuang J. L., Teng C. M. and Huang T. F. (1992) Triflavin, an Arg-Gly-Asp-containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line. Thromb. Res. 66: 679-691
98. Chiang H. S., Swain M. W. and Huang T. F. (1994) Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br. J. Haematol. 87: 325-331
99. Swain M. W., Chiang H. S. and Huang T. F. (1996) Characterization of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptide, trigramin and rhodostomin. Eur. J. Cancer 32: 715-721
100. Sato M., Sardana M. K., Grasser W. A., Garsky V. M., Murray J. M. and Gould R. J. (1990) Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111: 1713-1723
101. Fisher J. E., Caulfield M. P., Sato M., Quartuccia H. A., Gould R. J., Garsky V. M. et al. (1993) Inhibition of osteoclastic bone resorption in vivo by echistatin, an arginylglycyl-aspartyl (RGD)-containing protein. Endocrinology 132: 1411-1413
102. 3 integrins in hemostasis and vascular biology. Thromb. Haemost. 74: 149-155
103. 3 integrins. J. Biol. Chem. 271: 10365
104. Folkman J. and Shing Y. (1992) Angiogenesis, J. Biol. Chem. 267: 10931-10934
105. D'Amor P. A. and Thompson R. W. (1987) Mechanisms of angiogenesis. Ann. Rev. Physiol. 49: 453-464
106. Folkman J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Med. 1: 27
107. Weinstat-Saslow D. and Steeg P. S. (1994) Angiogenesis and colonization in the tumor metastatic process: basis and applied advances. FASEB J. 8: 401-407
108. Brooks P. C., Montgomery A. M. P., Rosenfeld M., Reisfeld R. A., Hu T., Klier G. et al. (1994) Integrin alpha-V beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164
109. Brooks P. C., Clark R. A. F. and Cheresh D. A. (1994) Requirement of vascular integrin alpha-V/beta-3 for angiogenesis. Science 264: 569-571
110. Brooks P. C., Stromblad S., Sanders L. C., von Schalscha T. L., Aimes T. T., Steler-Stevenson W. G. et al. (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha-V beta-3. Cell 85: 683-693
111. Hammes H. P., Brownlee M., Jonczyk A., Sutter A. and Preissner K. T. (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med. 2: 529-533
112. Chiang H. S., Yang R. S. and Huang T. F. (1995) Arg-Gly-Asp containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Saos-2 human osteosarcoma cells. Br. J. Cancer 71: 265-270
113. Sheu R. S., Lin C. H., Peng H. C. and Huang T. F. (1996) Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc. Soc. Exp. Biol. Med. 213: 71-79
114. Morris V. L., Schmidt E. E., Koop S., MacDonald I. C., Grattan Khokka R., McLane M. A. et al. (1995) Effects of disintegin eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res. 219: 571-578
115. Chang M. C., Wang B. R. and Huang T. F. (1995) Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp containing peptides. Thromb. Haemostas. 74: 764-769
116. 3 integrin binding and the subsequent activation of a G-protein coupled phospholipase C. Biochim Biophys. Acta 1269: 115-121
117. 3 and phospholipase C regulate prostacyclin formation of endothelial cells caused by ancrod-generated fibrin. Eur. J. Pharmacol. 297: 129-136
118. Zhou Q., Smith J. B. and Grossman M. H. (1995) Molecular cloning and expression of catrocollastatin, a snake venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. Biochem. J. 307: 411-417
119. Ohsaka A. (1979) Hemorrhagic, necrotinizing and edemaforming effect of snake venom. In: Handbook of Experimental Pharmacology, vol. 52, pp. 480-546
120. Takeya H., Oda K., Miyata J., Omori-Satoh T. and Iwanaga S. (1990) The complete amino acid sequence of high molecular mass haemorrhagic protein HR1B isolated from the venom of Trimeresurus flaroriridis. J. Biol. Chem. 265: 16068-16073
121. Bjarnason J. B. and Tu A. T. (1978) Hemorrhagic toxins from western diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry 17: 3395-3404
122. Bjarnason J. B. and Fox J. W. (1994) Hemorrhagic metalloproteinases from snake venoms. Pharmacol. Ther. 62: 325-372
123. Au L. C., Huang Y. B., Huang T. F. and Choo K. B. (1991) A common precursor for a putative haemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of venom Calloselasma rhodostoma: molecular cloning and sequence analysis. Biochem. Biophys. Res. Commun. 181: 585-593
124. Au L. C., Chou J. S., Chang K. J., Teh G. W. and Lin S. B. (1993) Nueleotide sequence of a full-length cDNA encoding a common precursor of platelet aggregation inhibitor and haemorrhagic protein from Calloselasma rhodostoma venom. Biochim. Biophys. Acta 1173: 243-245
125. Neeper M. P. and Jacobson M. A. (1990) Sequence of a cDNA encoding the platelet aggregation inhibitor trigramin. Nucleic Acids Res. 18: 4255
126. Fox J. W. and Bjarnason J. B. (1995) The retrolysins: a family of metalloproteases defined by snake venom and mammalian metalloproteases. In: Zinc Metalloproteases in Health and Disease, Hooper N. (ed.), Ellis Horwood, West Sussex
127. Kamiguti A. S., Hay C. R. M., Theakston R. D. G. and Zuzel M. (1996) Insight into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 34: 627-642
128. Smith J. B., Dangelmaier C. and Selak M. (1991) Identification of 50 kDa snake venom proteins which specifically inhibit platelet adhesion to collagen. FEBS Lett. 283: 307-310
129. Zhou Q., Dangelmaire C. and Smith J. B. (1996) The hemorrhagin catrocollastin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun. 219: 720-726
130. Liu C. Z. and Huang T. F. (1997) Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch. Biochem. Biophys. 337: 291-299
131. 1. Biochem. Biophys. Res. Commun. 206: 570-576
132. Kamiguti A. S., Hay C. R. and Zuzel M. (1996) Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloprotease Jararhagin. Biochem. J. 320: 635-641
133. Teng C. M., Ko F. N., Tsai I. H., Huang M. L. and Huang T. F. (1993) Trimucytin, a collagen-like aggregation inducer isolated from Trimeresurua mucrosquamatus snake venom. Thromb. Haemostas. 69: 286-292
134. Huang T. F., Liu C. Z. and Yang S. H. (1995) Aggretin, a novel platelet aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J. 309: 1021-1027
135. Grunwald G. B. (1993) The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr. Opin Cell Biol. 5: 797
136. Springer T. A. (1990) Adhesion receptors of the immune system. Nature 346: 425-434
137. Bevilacqua M., Butcher E., Furie B., Furie B., Gallatin M., Gimbrone M. et al. (1991) Selectins: a family of adhesion receptors. Cell 67: 233
138. Blobel C. P., Wolfsberg T. G., Turck C. W., Myles D. G., Primakoff P. and White J. M. (1992) A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356: 248-252
139. Wolfsberg T. G., Straight P. D., Gerena R., Huvovila A-P. J., Primakoff P., Myles D. G. et al. (1995) ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169: 378-383
140. Wassarman P. M. (1995) Towards a molecular mechanism for gamete adhesion and fusion during mammalian fertilization. Curr. Opin. Cell Biol. 2: 658-664
141. 1 functions as a sperm receptor. Cell 81: 1095-1104
142. Perry A. C. F., Jones R. and Barker P. J. (1992) A mammalian epididymal protein with remarkable sequence similarity to snake venom haemorrhagic peptides. Biochem. J. 286: 671-675
143. Kratzschmar J., Lum L. and Blobel C. P. (1996) Metargidin. a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J. Biol. Chem. 271: 4593-4596
144. Pawson T. (1995) Protein modules and signalling networks. Nature 373: 573-580
145. Weskamp G., Kratzschmar J., Reid M. S. and Blobel C. P. (1996) MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 132: 717-726
146. Henandez L. D., Huffman L. R., Wolfsborg T. G. and White J. M. (1996) Virus-cell and cell-cell fusion. Ann. Rev. Cell Dev. Biol. 12: 627-661
147. 1 is localized at specific sites of cell-to-cell contact in rat seminiferous epithelium. Biol. Reprod. 52: 79-87
148. Rooke J., Pan D., Xu T. and Rubin G. M. (1996) Kuz, a conserved metalloprotease-disintegrin prokin with two roles in Drosophila neurogenesis. Science 273: 1227-1231
149. Herren B., Raines E. W. and Ross R. (1997) Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J. 11: 173-180
150. Moake J. L., Turner N. A., Stathopoulos N. A., Nolasco L. and Hellums J. D. (1988) Shear-induced platelet aggregation can be mediated by vWF released from platelet, as well as by exogenous large or unusually large vWF multimers, requires adensine diphosphate and is resistant to aspirin. Blood 71: 1366-1374
151. Ikeda Y., Handa M., Kamata K., Kawai Y., Watanabe K., Kawakami K. et al. (1993) Transmembrane calcium influx associated with von Willebrand factor binding to GP1b in the initiation of shear-induced platelet aggregation. Thromb. Haemostas. 69: 496-502
152. Alevridou B. R., Moake J. L., Turner N. A., Ruggeri Z. M., Folie B. J., Phillips M. D. et al. (1993) Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 69: 1263-1276
153. Savage B., Sadlivar E. and Ruggeri Z. M. (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84: 289-297
154. Fujimura Y., Kawasaki T. and Titani K. (1996) Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb. Haemostas. 76: 633-639